Barber R, Gholkar A, Scheltens P, Ballard C, McKeith I G, O'Brien J T
Institute for the Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, UK.
Neurology. 1999 Apr 12;52(6):1153-8. doi: 10.1212/wnl.52.6.1153.
To investigate whether medial temporal lobe atrophy (MTA) on MRI is less frequent in dementia with Lewy bodies (DLB) compared with AD and vascular dementia (VaD), and to determine the diagnostic utility of MTA in the differential diagnosis of dementia.
Coronal T1-weighted 1.0-T MR images were acquired in patients with DLB (consensus criteria; n = 26; mean age, 75.9 years), AD (National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association; n = 28; mean age, 77.4 years), VaD (National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences; n = 24; mean age, 76.9 years), and normal control subjects (n = 26; mean age, 76.2 years). Cognitive function was assessed using the Cambridge Cognitive Examination (CAMCOG), and MTA was rated visually using a standardized scale.
MTA was more frequent and severe in all dementia groups compared with control subjects (AD, 100%; VaD, 88%; DLB, 62%; control subjects, 4%; p < 0.001). Comparing dementia groups, MTA scores were significantly lower in DLB than AD (p = 0.002), with a trend toward less atrophy in DLB compared with VaD (p = 0.07). The absence of MTA had a specificity of 100% and 88% for separating DLB from AD and VaD respectively, and a sensitivity of 38%. In patients with DLB, MTA increased with age (r = 0.58, p = 0.002), and in all dementia patients MTA correlated with memory impairment (combined memory score, r = -0.34, p = 0.003) but not total CAMCOG score or other subscales.
Patients with DLB have significantly greater MTA than control subjects but significantly less than those with AD. The authors confirmed that the presence of MTA is useful in detecting AD but less useful in differentiating between dementias. However, in the differentiation of DLB from AD and VaD, the absence of MTA is highly suggestive of a diagnosis of DLB.
研究与阿尔茨海默病(AD)和血管性痴呆(VaD)相比,路易体痴呆(DLB)患者磁共振成像(MRI)上内侧颞叶萎缩(MTA)的发生率是否更低,并确定MTA在痴呆鉴别诊断中的诊断效用。
对DLB患者(符合共识标准;n = 26;平均年龄75.9岁)、AD患者(美国国立神经疾病和中风研究所-阿尔茨海默病及相关疾病协会标准;n = 28;平均年龄77.4岁)、VaD患者(美国国立神经疾病和中风研究所-国际神经科学研究与教学协会标准;n = 24;平均年龄76.9岁)以及正常对照者(n = 26;平均年龄76.2岁)进行1.0-T冠状位T1加权MR成像。使用剑桥认知检查(CAMCOG)评估认知功能,并使用标准化量表对MTA进行视觉评分。
与对照者相比,所有痴呆组的MTA发生率更高且更严重(AD组为100%;VaD组为88%;DLB组为62%;对照组为4%;p < 0.001)。比较痴呆组,DLB的MTA评分显著低于AD组(p = 0.002),与VaD组相比,DLB有萎缩程度较轻的趋势(p = 0.07)。MTA阴性对将DLB与AD和VaD区分开的特异性分别为100%和88%,敏感性为38%。在DLB患者中,MTA随年龄增加(r = 0.58,p = 0.002),在所有痴呆患者中,MTA与记忆障碍相关(综合记忆评分,r = -0.34,p = 0.003),但与CAMCOG总分或其他子量表无关。
DLB患者的MTA明显高于对照者,但显著低于AD患者。作者证实MTA的存在有助于检测AD,但在区分不同痴呆方面作用较小。然而,在DLB与AD和VaD的鉴别中,MTA阴性高度提示DLB的诊断。